ARCHIVES

FDA Approves Rituxan For CLL

This article is from The Cancer Letter archive.

Vol. 36 No. 06 | February 19, 2010

Download PDF Visit The Full Archive

Related Articles

Evidence Too Weak to Link Agent Orange, Cancer, IOM Says

March 22, 2002

AACR, ASCO Publish Reports Examining U.S. Cancer Care

April 4, 2014

Gilotrif Increases PFS Compared to Erlotinib In LUX-Lung 8 Phase III Head-to-Head Trial

October 31, 2014

Cold Spring Harbor Joins SWOG, Becoming First Lab To Join Cooperative Group

November 4, 2011

NIH Defends NCI Sponsored Travel

December 3, 2010

Protocols Approved By NCI During January 2004

February 27, 2004